The King’s Fund has recently published a document on what the future of dermatology services might look like. It was an independent report, funded by the British Association of Dermatologists. Evidence was taken from primary, secondary and intermediate care services and looked at various models …
Articles: 26.13-16 July-August 2015
With an increasing choice of non-oral contraceptives available it is important that patients understand the risks and benefits of each option. Our drug review discusses the properties, efficacy and suitability of currently available non-oral contraceptives.
Nonoral contraceptive options how to find the right fit
Apremilast (Otezla), a new oral PDE4 inhibitor, is licensed for the treatment of plaque psoriasis and psoriatic arthritis. Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Dr Giles Dunnill discusses its place in therapy.
Otezla for plaque psoriasis and psoriatic …
Tremor is a common complaint but making a definitive diagnosis can be difficult. This review offers practical tips on how to differentiate different tremor types and reviews current treatment options.
Practical tips on diagnosing and managing tremor